GSDMD and Hepatic fibrosis: Immunohistochemical (IHC) analysis revealed that the expression of hepatic GSDMD, IL-1β, and IL-18 was significantly upregulated in patients with liver fibrosis compared to HCs (Figure 1A and Figure S1A).